Large-scale testing (Phase 3)Study completedNCT04204096
What this trial is testing
Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)
Who this might be right for
Typhoid
International Vaccine Institute 1,800